Filings

5 documents · 74 matches

1. ALGS Aligos Therapeutics, Inc. 10-K 2026-03-05

   Item 1A. Risk Factors.

   going concern. Substantial doubt about our ability to continue as a going concern may materially and adversely affect the price
   21 matches in this document Show context Copy citation

2. ALGS Aligos Therapeutics, Inc. 10-Q 2025-11-06

   Item 1A. Risk Factors.

   going concern. We have devoted our resources to our research and development activities and have experienced significant operating losses since
   13 matches in this document Show context Copy citation

3. ALGS Aligos Therapeutics, Inc. 10-Q 2026-11-06

   Item 1. Financial Statements.

   Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
   13 matches in this document Show context Copy citation

4. ALGS Aligos Therapeutics, Inc. 10-Q 2026-08-06

   Item 1. Financial Statements.

   Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
   13 matches in this document Show context Copy citation

5. ALGS Aligos Therapeutics, Inc. 10-Q 2026-05-07

   Item 1. Financial Statements.

   Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
   14 matches in this document Show context Copy citation